Combination of the anti-CD30-auristatin-E antibody-drug conjugate SGN-35 with chemotherapy improves antitumor activity in Hodgkin's lymphoma

被引：0
|
作者：
Oflazoglu, E. [1 ]
Kennedy, D. [2 ]
Sievers, E. L. [2 ]
Kissler, K. M. [1 ]
Jonas, M. [3 ]
Ihle, N. C. [4 ]
Grewal, I. S. [1 ]
Gerber, H. [1 ]
机构：
[1] Seattle Genet Inc, Preclin Therapeut, Bothell, WA USA
[2] Seattle Genet Inc, Clin, Bothell, WA USA
[3] Seattle Genet Inc, Antibody Technol, Bothell, WA USA
[4] Seattle Genet Inc, Proc Chem, Bothell, WA USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：235 / 236
页数：2
相关论文
共 50 条
  • [41] SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models
    Mazahreh, Rebecca
    Mason, Marsha L.
    Gosink, John J.
    Olson, Devra J.
    Thurman, Robert
    Hale, Christopher
    Westendorf, Lori
    Pires, Thomas A.
    Leiske, Christopher I.
    Carlson, Markus
    Nguyen, Liem T.
    Cochran, Julia H.
    Okeley, Nicole M.
    Yumul, Roma
    Jin, Steven
    Stone, Ivan J.
    Sahetya, Disha
    Nesterova, Albina
    Allred, Sean
    Hensley, Kelly M.
    Hu, Rachael
    Lawrence, Robert
    Lewis, Timothy S.
    Sandall, Sharsti
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (04) : 421 - 434
  • [42] Ags67e, an anti-cd37 monomethyl auristatin e antibody (mmae) drug conjugate as a potential therapeutic for non-hodgkin's lymphoma, chronic lymphocytic leukemia and acute myeloid leukemia
    Pereira, Daniel S.
    Guevara, Claudia
    Verlinsky, Alla
    Virata, Cyrus
    Ssucheng, J. Hsu
    An, Zili
    Zhang, Chungying
    Dinh, Nick
    Avina, Hector
    Do, Lisa
    Karki, Sher
    Abad, Joseph
    Yang, Peng
    Ou, Jimmy
    Morrison, Karen
    Moon, Sing-Ju
    Malik, Faisal
    Jin, Liqing
    Choi, Michael
    Wu, Christina
    Anand, Banmeet
    Cooper, Scott
    Joseph, Ingrid
    Jia, Xiao-Chi
    Morrison, Kendall
    Challita-Eid, Pia
    Donate, Fernando
    Kipps, Thomas
    Dick, John
    Stover, David
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Humanized anti-CD19 auristatin antibody-drug conjugates display potent antitumor activity in preclinical models of B-cell malignancies.
    Gerber, Hans-Peter
    Morris-Tilden, Carol
    Stone, Ivan
    Jonas, Mechthild
    Kung-Sutherland, May
    Miyamoto, Jamie
    Brown, Lindsay
    Westendorf, Lori
    Meyer, Damon
    Sussman, Django
    Carter, Paul
    Law, Che-Leung
    Grewal, Iqbal S.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3451S - 3451S
  • [44] Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma
    Dornan, David
    Bennett, Fiona
    Chen, Yvonne
    Dennis, Mark
    Eaton, Dan
    Elkins, Kristi
    French, Dorothy
    Go, Mary Ann T.
    Jack, Andrew
    Junutula, Jagath R.
    Koeppen, Hartmut
    Lau, Jeffrey
    McBride, Jacqueline
    Rawstron, Andy
    Shi, Xiaoyan
    Yu, Nancy
    Yu, Shang-Fan
    Yue, Peng
    Zheng, Bing
    Ebens, Allen
    Polson, Andrew G.
    BLOOD, 2009, 114 (13) : 2721 - 2729
  • [45] Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating Effects
    Morelli, Feliciana
    Matis, Serena
    Benelli, Roberto
    Salvini, Laura
    Zocchi, Maria Raffaella
    Poggi, Alessandro
    CELLS, 2024, 13 (10)
  • [46] Development and Therapeutic Potential of an Anti-CD79b Antibody-Drug Conjugate, Anti-CD79b-Vc-MMAE, for the Treatment of Non-Hodgkin's Lymphoma.
    Polson, Andrew G.
    Bennett, Fiona L.
    Chen, Yvonne
    Dennis, Mark
    Eaton, Dan
    Ebens, Allen
    Elkins, Kristi
    French, Dorothy
    Go, Mary Ann T.
    Jack, Andrew S.
    Junutula, Jagath
    Koeppen, Hartmut
    Lau, Jeffery
    McBride, Jacqueline
    Shi, Lily
    Rawston, Andy
    Yu, Shang-Fan
    Yue, Peng
    Zheng, Bing
    Doman, David
    BLOOD, 2008, 112 (11) : 906 - 907
  • [47] An Anti-CD22-seco-CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models
    Yu, Shang-Fan
    Lee, Donna W.
    Zheng, Bing
    Del Rosario, Geoffrey
    Leipold, Douglas
    Booler, Helen
    Zhong, Fiona
    Carrasco-Triguero, Montserrat
    Hong, Kyu
    Yan, Peter
    Rowntree, Rebecca K.
    Schutten, Melissa M.
    Pillow, Thomas
    Sadowsky, Jack D.
    Dragovich, Peter S.
    Polson, Andrew G.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (02) : 340 - 346
  • [48] SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML
    Sutherland, May S. K.
    Walter, Roland B.
    Jeffrey, Scott C.
    Burke, Patrick J.
    Yu, Changpu
    Harrington, Kimberly H.
    Stone, Ivan
    Ryan, Maureen C.
    Sussman, Django
    Zeng, Weiping
    Benjamin, Dennis R.
    Bernstein, Irwin D.
    Senter, Peter D.
    Drachman, Jonathan G.
    McEarchern, Julie A.
    BLOOD, 2012, 120 (21)
  • [49] A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity
    Jiang, Linlin
    Yang, Ming
    Zhang, Xiaoyun
    Bao, Shiqi
    Ma, Li
    Fan, Dongmei
    Zhou, Yuan
    Xiong, Dongsheng
    Zhen, Yongsu
    JOURNAL OF DRUG TARGETING, 2016, 24 (01) : 47 - 57
  • [50] Brentuximab vedotin (SGN-35) treatment in relapsed CD30-positive Hodgkin's lymphoma patients following allogeneic stem cell transplant: a multi-centre case series
    Gopal, A. K.
    Ramchandren, R.
    Berryman, R. B.
    Advani, R. H.
    Chen, R.
    Smith, S.
    Cooper, M.
    Engert, A.
    Matous, J.
    Zain, J.
    Grove, L. E.
    Hunder, N. N.
    O'Connor, O. A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S36 - S36
12345